The National Agency for Food and Drug Administration and Control (NAFDAC), has approved the production of chloroquine for clinical trials.
According to the Director General Mojisola Adeyeye, the agency was not approving Chloroquine for the treatment of COVlD-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that can be used for Coronavirus because there is no submission to us for registration, but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
“Therefore, the medicine is being approved just for the clinical trials,” Adeyeye said.
Furthermore, she called on experts and researchers that were interested in doing a clinical trial on Chloroquine to approach approved outlets.